Reply: Bronchiolocentric interstitial pneumonia is a morphological term used for lung biopsy and chest imaging pattern and is not a substitute for hypersensitivity pneumonitis

<title>Extract</title> The 2025 European Respiratory Society (ERS)/American Thoracic Society (ATS) task force statement on classification of the interstitial pneumonias was undertaken with a primary goal to simplify the overall approach and standardise terminology for the collection of diffuse lung disorders that affect the interstitial and/or alveolar spaces [1]. This new document updates previous consensus classifications from 2002 and 2013 [2, 3]. G. Raghu and co-workers had differing views from the majority of the 2025 task force committee on the use of “bronchiolocentric interstitial pneumonia” (BIP) as the term for a major interstitial pneumonia pattern that is distinguished from other interstitial patterns by the presence of bronchiolocentric abnormalities. After extensive attempts to find common ground between these perspectives, G. Raghu and co-workers chose to not remain as co-authors of the final document. E.R. Fernández Pérez, and M. Selman and I. Buendía Roldán, have also raised questions about this topic.

Authors

Institutions

Publication Details

Journal
European Respiratory Journal
Published
2025-12-01
DOI
https://doi.org/10.1183/13993003.02009-2025
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reply: Bronchiolocentric interstitial pneumonia is a morphological term used for lung biopsy and chest imaging pattern and is not a substitute for hypersensitivity pneumonitis

Yoshikazu Inoue, Elisabetta Renzoni, Claudia Ravaglia, Letícia Kawano-Dourado et al.
European Respiratory Journal
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Reply: Bronchiolocentric interstitial pneumonia is a morphological term used for lung biopsy and chest imaging pattern and is not a substitute for hypersensitivity pneumonitis

Yoshikazu Inoue, Elisabetta Renzoni, Claudia Ravaglia, Letícia Kawano-Dourado, Simon Walsh, Takeshi Johkoh, Lida P. Hariri, Sara Piciucchi, Christopher J. Ryerson, Paul J. Wolters, Nicola Sverzellati, Marlies Wijsenbeek, Kerri A. Johannson, Aurélie Fabre, Ryoko Saito, Yet Hong Khor, Toby M. Maher, Amita Sharma, Katerina M. Antoniou, Philip L. Molyneaux, Ayodeji Adegunsoye, Soo‐Ryum Yang, Wendy A. Cooper, Raphaël Borie, Ella A. Kazerooni, Andrew G. Nicholson, William D. Travis, Athol U. Wells, Raymond Protti
article en

Abstract

<title>Extract</title> The 2025 European Respiratory Society (ERS)/American Thoracic Society (ATS) task force statement on classification of the interstitial pneumonias was undertaken with a primary goal to simplify the overall approach and standardise terminology for the collection of diffuse lung disorders that affect the interstitial and/or alveolar spaces [1]. This new document updates previous consensus classifications from 2002 and 2013 [2, 3]. G. Raghu and co-workers had differing views from the majority of the 2025 task force committee on the use of “bronchiolocentric interstitial pneumonia” (BIP) as the term for a major interstitial pneumonia pattern that is distinguished from other interstitial patterns by the presence of bronchiolocentric abnormalities. After extensive attempts to find common ground between these perspectives, G. Raghu and co-workers chose to not remain as co-authors of the final document. E.R. Fernández Pérez, and M. Selman and I. Buendía Roldán, have also raised questions about this topic.

European Respiratory JournalVol. 66(6)
University College Dublin (IE), Délégation Paris 5 (FR), University of Southern California (US), University of Parma (IT), Memorial Sloan Kettering Cancer Center (US), Harvard University (US), University of British Columbia (CA), University of Crete (GR), Inserm (FR), The University of Melbourne (AU), University of Calgary (CA), Universidade de São Paulo (BR), University of California, San Francisco (US), Guy's and St Thomas' NHS Foundation Trust (GB), Université Paris Cité (FR), University of Michigan (US), Royal Prince Alfred Hospital (AU), Royal Brompton & Harefield NHS Foundation Trust (GB), House of Representatives (NL), Harefield Hospital (GB), University of California System (US), University of Chicago (US), Massachusetts General Hospital (US), Monash Alfred Psychiatry Research centre (AU), Royal Brompton Hospital (GB), Assistance Publique – Hôpitaux de Paris (FR), Institute for Breathing and Sleep (AU), Hospital TotalCor (BR), Lung Institute (US), Kansai Rosai Hospital (JP), Michigan Medicine (US), St. Vincent's University Hospital (IE), Sendai Medical Center (JP), Ospedale G.B. Morgagni - L.Pierantoni (IT), Canadian Patient Safety Institute (CA), Eight19 (United Kingdom) (GB), The London College (GB), Hôpital Bichat-Claude-Bernard (FR), Fukujuji Hospital (JP), NHO Kinki Chuo Chest Medical Center (JP), Hospital São Paulo (BR), Austin Health (AU), Imperial College London (GB), Monash University (AU), Erasmus University Rotterdam (NL), University of Bologna (IT)
Openalex Percentile: Top 43%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.